GYRE
Financials
- Market Capitalization 636.51 M
- Employee 618
- Founded 1997
- CEO N/A
- Website www.gyretx.com
- Headquarter Delaware, United States
- FIGI BBG000F88SY8
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2746 |  RLMD Relmada Therapeutics, Inc. - Common Stock | 6.21 USD | 0.00% | -2.66% | -5.19% | +918.03% | 651.37 M USD | ||
| 2748 |  ACHV Achieve Life Sciences, Inc. - Common Shares | 6.33 USD | +0.32% | +1.12% | +13.64% | +134.44% | 649.83 M USD | ||
| 2761 |  MDXG MiMedx Group, Inc - Common Stock | 4.27 USD | +1.67% | +0.95% | +15.41% | -36.08% | 636.00 M USD | ||
| 2765 |  RGNX REGENXBIO Inc. - Common Stock | 12.27 USD | -0.16% | -20.07% | +70.42% | -8.64% | 634.33 M USD |
Frequently asked questions about Gyre Therapeutics, Inc. - Common Stock
What is the Gyre Therapeutics, Inc. - Common Stock stock price today?
The current price of Gyre Therapeutics, Inc. - Common Stock (GYRE) is 6.5600000000000005. Over the past 24 hours, the stock has changed by +3.47%. Follow the GYRE chart for real-time price dynamics.
What is the stock ticker of Gyre Therapeutics, Inc. - Common Stock?
Gyre Therapeutics, Inc. - Common Stock trades under the ticker GYRE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Gyre Therapeutics, Inc. - Common Stock stock going up?
GYRE has changed by -3.53% over the last week, +12.33% over the last month, and -20.58% over the last year. Review the chart to see whether the current move is part of a broader trend.
Does Gyre Therapeutics, Inc. - Common Stock release financial reports?
Yes. You can track Gyre Therapeutics, Inc. - Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.
What was Gyre Therapeutics, Inc. - Common Stock net income for the last quarter?
Gyre Therapeutics, Inc. - Common Stock reported net income of -9.86 M for the last quarter. The previous quarter showed -1.37 M, which means net income changed by -621.67%.
How many employees does Gyre Therapeutics, Inc. - Common Stock have?
As of the latest available data, Gyre Therapeutics, Inc. - Common Stock has 618 employees. Workforce size can provide additional context about the company's scale and operations.
What is Gyre Therapeutics, Inc. - Common Stock EBITDA?
Gyre Therapeutics, Inc. - Common Stock EBITDA is -8.68 M, and its EBITDA margin is -38.56%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Gyre Therapeutics, Inc. - Common Stock stock?
You can buy Gyre Therapeutics, Inc. - Common Stock (GYRE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Gyre Therapeutics, Inc. - Common Stock stock?
Investing in Gyre Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the GYRE chart and related analysis on metatrader.com as part of your research.